Quick Takeaways
- AdvisorShares Trust filed SCHEDULE 13G/A for InMed Pharmaceuticals Inc. Common Shares, no par value (INM).
- Disclosed ownership: 0%.
- Date of event: 31 Mar 2025.
AdvisorShares Trust - 31 Mar 2025 SCHEDULE 13G/A Report for InMed Pharmaceuticals Inc. Common Shares, no par value (INM)
- Filing Manager
- AdvisorShares Trust
- Reporting Manager
- AdvisorShares Trust
- Symbol
- INM
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 02 Apr 2025, 16:13:23 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AdvisorShares Trust disclosed 0% ownership in InMed Pharmaceuticals Inc. Common Shares, no par value (INM) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 02 Apr 2025, 16:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AdvisorShares Trust | 0% | 0 | 0 | 0 | /s/ Stefanie Lititle | Stefanie Little - Chief Compliance Officer |